Cochrane · systematic review · CD012825
Anti‐inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack
Coveney, S, McCabe, JJ, Murphy, S, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
StrokeAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
0
No studies
7
Included studies
NR
No studies 7 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: patients with TIA or ischaemic stroke
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Number of patients with all vascular events (stroke, MI, non‐fatal cardiac arrest, unstable angina requiring revascularisation, vascular death) at 90 days and at 1 year | no estimate extracted | NR | No studies |
Number of patients with safety events (total AEs, infections, SAEs) | no estimate extracted | NR | No studies |
Number of patients with recurrent stroke (fatal and non‐fatal) at 90 days and at 1 year | no estimate extracted | NR | No studies |
Number of patients with all‐cause death | no estimate extracted | NR | No studies |
Number of patients with cardiovascular death | no estimate extracted | NR | No studies |
Number of patients with infection | no estimate extracted | NR | No studies |
Number of patients with non‐scheduled hospitalisation | no estimate extracted | NR | No studies |